Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines

Patent 11913013 was granted and assigned to Sabin Vaccine Institute on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Sabin Vaccine Institute
Sabin Vaccine Institute
0
Date Filed
July 30, 2021
0
Date of Patent
February 27, 2024
0
Patent Application Number
17389421
0
Patent Citations
‌
US Patent 8101739 Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector
0
‌
US Patent 9718863 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
0
‌
US Patent 8216834 Chimpanzee adenovirus vaccine carriers
0
Patent Inventor Names
Alfredo Nicosia
0
Stefano Colloca
0
Riccardo Cortese
0
Gary J. Nabel
0
Cheng Cheng
0
Clement Asiedu
0
Nancy J. Sullivan
0
Virginia Ammendola
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11913013
0
Patent Primary Examiner
‌
Jeffrey S. Parkin
0
CPC Code
‌
C12N 2760/14134
0
‌
C12N 2710/10341
0
‌
C12N 15/861
0
‌
C12N 15/86
0
‌
A61K 39/12
0

Find more entities like US Patent 11913013 Chimpanzee adenoviral vector-based filovirus vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo